From: Treatment outcomes of reduced-dose intravitreal ganciclovir for cytomegalovirus retinitis
Factors | Univariate | Multivariate | ||
---|---|---|---|---|
p | HR (95 % CI) | p | HR (95 % CI) | |
Age younger than 45 years old | 0.013 | 2.86 (1.25–6.67) | 0.033 | 2.5 (1.08–5.88) |
Male | 0.247 | 1.46 (0.77–2.67) | 0.382 | 1.51 (0.60–3.83) |
Induction with intravenous ganciclovir | 0.798 | 1.09 (0.57–2.07) | 0.494 | 1.26 (0.65–2.44) |
Initial CD4 > 100 | 0.287 | 1.58 (0.68–3.67) | ||
Concurrent anti-retroviral therapy | 0.324 | 1.43 (0.70–2.92) | ||
Initial visual acuity of 6/60 or better | 0.335 | 1.42 (0.69–2.92) | ||
No zone 1 involvement | 0.717 | 1.12 (0.60–2.08) | 0.091 | 0.50 (0.23–1.12) |
Area of retinitis less than 25 % | 0.258 | 1.45 (0.76–2.78) | 0.500 | 1.41 (0.52–3.83) |
No foveal involvement | 0.162 | 1.64 (0.82–3.29) | 0.023 | 2.65 (1.14–6.11) |
No disc involvement | 0.345 | 1.43 (0.68–3.01) | ||
Frosted branch angiitis not presented | 0.007 | 2.58 (1.29–5.16) | 0.003 | 3.45 (1.52–7.83) |